[{"Assets_0_Q1_USD":"17772200000.0","CIK":"872589","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"10.58","EarningsPerShareDiluted_1_Q1_USD":"10.09","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"77738004554.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"668500000.0","NetIncomeLoss_1_Q1_USD":"1115200000.0","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","RevenuesConverted_1_Q1_USD":"2528700000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q1_USD":"11977000000.0","Ticker":"REGN","TreasuryStockSharesConverted_0_Q1_shares":"17104177.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"110500000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"105400000.0","filed":"20210506","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"REGENERON PHARMACEUTICALS, INC.","period":"20210331","qtrs":"1","uom":"USD"}]